Myosin, Smooth Muscle (SMMS-1) Mouse Monoclonal Antibody
Specialties: Breast/Gynecological Pathology
Detection of smooth muscle myosin, heavy chain (SMMS-1) in myoepithelial cells by immunohistochemistry (IHC) with Myosin, Smooth Muscle (SMMS-1) Mouse Monoclonal Antibody may be used to aid in the diagnosis of breast carcinomas.
Smooth Muscle Myosin, heavy chain (SMMS-1) is a cytoplasmic protein that interacts with actin to produce smooth muscle contraction. SMMS-1 is normally found in smooth muscle and myoepithelial cells.1 Myoepithelial cells line the ducts of both benign breast tissue and breast carcinoma in situ but are lost in invasive breast carcinomas. Immunohistochemistry for SMMS-1 labels myoepithelial cells and shows positive staining in benign breast and in-situ carcinomas, which show a retained myoepithelial cell layer, but shows no staining in invasive breast carcinomas.1-4 Immunohistochemistry for SMMS-1 shows a cytoplasmic pattern of staining.
- Lazard, D et al. "Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue." Proceedings of the National Academy of Sciences of the United States of America vol. 90,3 (1993): 999-1003.
- Werling, Robert W et al. "Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain." The American journal of surgical pathology vol. 27,1 (2003): 82-90.
- Kalof, A N et al. "Immunostaining patterns of myoepithelial cells in breast lesions: a comparison of CD10 and smooth muscle myosin heavy chain."ÃÂ Journal of clinical pathology vol. 57,6 (2004): 625-9.
- Dewar, Rajan et al. "Best practices in diagnostic immunohistochemistry: myoepithelial markers in breast pathology." Archives of pathology & laboratory medicine"ÃÂ vol. 135,4 (2011): 422-9.
- Nadji M, Morales AR. Immunoperoxidase, part I: the techniques and its pitfalls. Lab Med 1983;14:767
- Omata M, Liew CT, Ashcavai M, Peters RL. Nonimmunologic binding of horseradish peroxidase to hepatitis B surface antigen. A possible source of error in immunohistochemistry. Am J Clin Pathol. 1980 May; 73(5):626-32. doi: 10.1093/ajcp/73.5.626. PMID: 6155065.
Specifications
- Reactivity: paraffin
- Control: Breast (Cytoplasmic)
- Dilution Range: 1:100-1:500 *
Package Inserts
IFU
- IVD Rev. 6.0 (CMC29821060)
Have a different keycode?
Click Here
Learn how to obtain your SDS
Ordering Information
For in vitro diagnostic (IVD) use in USA
| 0.1 mL concentrate | 298M-14 |
| 0.5 mL concentrate | 298M-15 |
| 1.0 mL concentrate | 298M-16 |
| 1.0 mL predilute ready-to-use | 298M-17 |
| 7.0 mL predilute ready-to-use | 298M-18 |
For in vitro diagnostic (IVD) use in Canada
| 0.1 mL concentrate | 298M-14 |
| 0.5 mL concentrate | 298M-15 |
| 1.0 mL concentrate | 298M-16 |
| 1.0 mL predilute ready-to-use | 298M-17 |
| 7.0 mL predilute ready-to-use | 298M-18 |
For in vitro diagnostic (IVD) use in Europe
| 0.1 mL concentrate | 298M-14 |
| 0.5 mL concentrate | 298M-15 |
| 1.0 mL concentrate | 298M-16 |
| 1.0 mL predilute ready-to-use | 298M-17 |
| 7.0 mL predilute ready-to-use | 298M-18 |
For research use only (RUO) in Japan
| 0.1 mL concentrate (RUO | 298M-14-RUO |
| 0.5 mL concentrate (RUO | 298M-15-RUO |
| 1.0 mL concentrate (RUO | 298M-16-RUO |
| 1.0 mL predilute ready-to-use (RUO | 298M-17-RUO |
| 7.0 mL predilute ready-to-use (RUO | 298M-18-RUO |
To request information on this product in additional countries, please click the button below.








